Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
851
mi
from 43215
Oklahoma City, OK
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
851
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
463
mi
from 43215
Orangeburg, SC
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
463
mi
from 43215
Orangeburg, SC
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
995
mi
from 43215
Houston, TX
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
934
mi
from 43215
Wellington, FL
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
934
mi
from 43215
Wellington, FL
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
797
mi
from 43215
New Orleans, LA
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
797
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from 43215
Middelburg,
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from 43215
Middelburg,
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
1967
mi
from 43215
Cypress, CA
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
1967
mi
from 43215
Cypress, CA
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
981
mi
from 43215
Aventura, FL
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
981
mi
from 43215
Aventura, FL
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
627
mi
from 43215
Lenexa, KA
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
627
mi
from 43215
Lenexa, KA
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
537
mi
from 43215
New Haven, CT
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
274
mi
from 43215
Chicago, IL
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
460
mi
from 43215
Iowa City, IA
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
353
mi
from 43215
Chapel Hill, NC
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
994
mi
from 43215
Galveston, TX
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
994
mi
from 43215
Galveston, TX
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
1670
mi
from 43215
Calgary,
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
1670
mi
from 43215
Calgary,
Click here to add this to my saved trials
The Effects of a Standardized Management Plan on Children With Critical Asthma
The Effects of a Standardized Clinical Assessment Management Plan (SCAMP) on Clinical Outcomes in Children With Critical Asthma
Status: Enrolling
Updated:  1/4/2017
Boston Children's Hospital
643
mi
from 43215
Boston, MA
The Effects of a Standardized Management Plan on Children With Critical Asthma
The Effects of a Standardized Clinical Assessment Management Plan (SCAMP) on Clinical Outcomes in Children With Critical Asthma
Status: Enrolling
Updated: 1/4/2017
Boston Children's Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
1980
mi
from 43215
Bakersfield, CA
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
1980
mi
from 43215
Bakersfield, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
1975
mi
from 43215
Long Beach, CA
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
1975
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
582
mi
from 43215
Albany, GA
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
582
mi
from 43215
Albany, GA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
481
mi
from 43215
New York, NY
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
991
mi
from 43215
Houston, TX
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
885
mi
from 43215
McKinney, TX
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
885
mi
from 43215
McKinney, TX
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
2012
mi
from 43215
Tacoma, WA
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
2012
mi
from 43215
Tacoma, WA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
9157
mi
from 43215
Brisbane,
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
9157
mi
from 43215
Brisbane,
Click here to add this to my saved trials
World Trade Center Adolescent Health Study
Early Identification of World Trade Center Conditions in Adolescents
Status: Enrolling
Updated:  1/23/2017
NYU School of Medicine
479
mi
from 43215
New York, NY
World Trade Center Adolescent Health Study
Early Identification of World Trade Center Conditions in Adolescents
Status: Enrolling
Updated: 1/23/2017
NYU School of Medicine
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
625
mi
from 43215
Little Rock, AR
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
625
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1986
mi
from 43215
Fresno, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1986
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1959
mi
from 43215
Fullerton, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1959
mi
from 43215
Fullerton, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1968
mi
from 43215
Huntington Beach, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1968
mi
from 43215
Huntington Beach, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1980
mi
from 43215
Inglewood, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1980
mi
from 43215
Inglewood, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1961
mi
from 43215
Irvine, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1961
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1976
mi
from 43215
Long Beach, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1976
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1959
mi
from 43215
Orange, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
2014
mi
from 43215
Spring Valley, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
2014
mi
from 43215
Spring Valley, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
2045
mi
from 43215
Stockton, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
2045
mi
from 43215
Stockton, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1161
mi
from 43215
Colorado Springs, CO
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1161
mi
from 43215
Colorado Springs, CO
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1160
mi
from 43215
Denver, CO
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1160
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1171
mi
from 43215
Lakewood, CO
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1171
mi
from 43215
Lakewood, CO
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
1168
mi
from 43215
Wheat Ridge, CO
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
1168
mi
from 43215
Wheat Ridge, CO
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
531
mi
from 43215
Waterbury, CT
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
531
mi
from 43215
Waterbury, CT
Click here to add this to my saved trials